GM
Giovanni Melillo
Hematology & Oncology
Credentials: ·
Research
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 3,824 citations
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine · 2018 · 2,311 citations
Review · International Journal of Radiation Biology · 2006 · 490 citations
- ES
11 papers
William Figg
10 papers
9 papers
8 papers
- AS
5 papers
- AC
Alice Chen
5 papers
4 papers
4 papers
